Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort studyJaveria Muhammadzai, Shahid Ahmed, Bryan Brunet et al.|PLoS ONE|2022Cited by 11
Outcomes of patients with borderline-resectable pancreatic cancer treated with FOLFIRINOX versus gemcitabine plus nab-paclitaxel.Shaina D'Lee Templeton, Shahid Ahmed, Mike Moser et al.|Journal of Clinical Oncology|2019Cited by 1
Early Single-Center Experience With Irreversible Electroporation for Stage 2, 3, and 4 Pancreatic AdenocarcinomasChristopher J Wall, Mike Moser, Shahid Ahmed et al.|Pancreas|2022Cited by 1
Effects of early discontinuation of adjuvant chemotherapy (EDAC) and the timing of treatment on outcomes in patients with early-stage pancreatic cancer (ESPC): Result from a population-based retrospective cohort study.Javeria Muhammadzai, Shahid Ahmed, Mike Moser et al.|Journal of Clinical Oncology|2020Cited by 0